The iStent inject was safe and effective for treating multiple types of primary open-angle glaucoma individually and in conjunction with cataract surgery, according to data published in Journal of Cataract and Refractive Surgery.
“Elevated [IOP] is one of the major risk factors for development and progression of POAG [primary open-angle glaucoma], and its reduction is considered the only intervention proved to slow progression of the disease,” Wesam Shamseldin Shalaby, MD, of Wills Eye Hospital Glaucoma Research Center, Philadelphia, and colleagues wrote. “IOP reduction is